Aroniadis, Olga C.

Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection

Brandt, L. J., Aroniadis, O. C., Mellow, M., Kanatzar, A., Kelly, C., Park, T., Stollman, N., Rohlke, F., & Surawicz, C. (2012) · American Journal of Gastroenterology

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 672

Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients

Kelly, C. R., Ihunnah, C., Fischer, M., Khoruts, A., Surawicz, C., Afzali, A., Aroniadis, O., Barto, A., Borody, T., Giovanelli, A., et al. (2014) · American Journal of Gastroenterology

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 636

Fecal microbiota transplantation: past, present and future

Aroniadis, O. C., & Brandt, L. J. (2013) · Current Opinion in Gastroenterology

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 336

The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals

Agrawal, M., Aroniadis, O. C., Brandt, L. J., Kelly, C., Freeman, S., Surawicz, C., Broussard, E., Stollman, N., Giovanelli, A., Smith, B., et al. (2016) · Journal of Clinical Gastroenterology

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 186

Digestive Manifestations in Patients Hospitalized With Coronavirus Disease 2019

Elmunzer, B. J., Spitzer, R. L., Foster, L. D., Merchant, A. A., Howard, E. F., Patel, V. A., West, M. K., Qayed, E., Nustas, R., Zakaria, A., et al. (2021) · Clinical Gastroenterology and Hepatology

COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19

Cited by 110

Is Fecal Microbiota Transplantation the Answer for Irritable Bowel Syndrome? A Single-Center Experience

Pinn, D. M., Aroniadis, O. C., & Brandt, L. J. (2014) · American Journal of Gastroenterology

Gastrointestinal motility and disordersGut microbiota and health

Cited by 94

742 - A Double-Blind, Randomized, Placebo-Controlled Trial of Fecal Microbiota Transplantation Capsules (FMTC) for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Aroniadis, O. C., Brandt, L. J., Oneto, C., Feuerstadt, P., Sherman, A., Wolkoff, A. W., Downs, I. A., Zanetti-Yabur, A., Ramos, Y., Cotto, C. L., et al. (2018) · Gastroenterology

Gastrointestinal motility and disordersInflammatory Bowel Disease

Cited by 27